In recent SARS-Cov-2-induced COVID-19, treatment with G-CSF is not recommended even though COVID-19 is associated with neutropenia because of G-CSF-induced inflammation outcomes (Lazarus and Gale, 2021). This evidence concerns the gene CSF3 and COVID-19.